Aberrant signaling of TGF-β1 by the mutant Smad4 in gastric cancer cells

Cancer Letters

Volumn 196, Issue 2, 2003, Pages 197-206

  Ju, Hyang Ran ^a   Jung, Uhee ^a   Sonn, Chung Hee ^a   Yoon, Suk Ran ^a   Jeon, Jun Ho ^a   Yang, Young ^a   Lee, Kee Nyung ^a   Choi, Inpyo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Gastric tumor; Mitogen activated protein kinase; Mutation; Smad4; TGF 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PROTEIN P21; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EXON; GENE EXPRESSION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; TUMOR CELL; UPREGULATION;

INSERTION SEQUENCES;

EID: 0037969195     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00237-4     Document Type: Article

References (32)

1. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29:2001;117-129.
2. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell. 103:2000;295-309.
3. Massague J. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:2000;169-178.
4. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
5. Blanchette F., Rivard N., Rudd P., Grondin F., Attisano L., Dubois C.M. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J. Biol. Chem. 276:2001;33986-33994.
6. Yue J., Mulder K.M. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a smad-dependent pathway. J. Biol. Chem. 275:2000;35656.
7. Park S.H., Kim Y.S., Park B.K., Hougaard S., Kim S.J. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: implication for the loss of TGF-beta type II receptor expression. Oncogene. 20:2001;1235-1245.
8. Yang H.K., Kang S.H., Kim Y.S., Won K., Bang Y.J., Kim S.J. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells. Oncogene. 18:1999;2213-2219.
9. Akiyama Y., Iwanaga R., Ishikawa T., Sakamoto K., Nishi N., Nihei Z., Iwama T., Saitoh K., Yuasa Y. Mutations of the transforming growth factor-beta type II receptor gene are strongly related to sporadic proximal colon carcinomas with microsatellite instability. Cancer. 78:1996;2478-2484.
10. Samowitz W.S., Slattery M.L. Transforming growth factor-beta receptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. Am. J. Pathol. 151:1997;33-35.
11. Chen T., Carter D., Garrigue-Antar L., Reiss M. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res. 58:1998;4805-4810.
12. Chen T., Triplett J., Dehner B., Hurst B., Colligan B., Pemberton J., Graff J.R., Carter J.H. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res. 61:2001;4679-4682.
13. Hata A., Lo R.S., Wotton D., Lagna G., Massague J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature. 388:1997;82-87.
14. Moren A., Itoh S., Moustakas A., Dijke P., Heldin C.H. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4. Oncogene. 19:2000;4396-4404.
15. Riggins G.J., Kinzler K.W., Vogelstein B., Thiagalingam S. Frequency of Smad gene mutations in human cancers. Cancer Res. 57:1997;2578-2580.
16. Chen C.R., Kang Y., Massague J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor beta growth arrest program. Proc. Natl Acad. Sci. U.S.A. 98:2001;992-999.
17. Miyazono K. TGF-beta/SMAD signaling and its involvement in tumor progression. Biol. Pharm. Bull. 23:2000;1125-1130.
18. Powell S.M., Harper J.C., Hamilton S.R., Robinson C.R., Cummings O.W. Inactivation of Smad4 in gastric carcinomas. Cancer Res. 57:1997;4221-4224.
19. Xu X., Brodie S.G., Yang X., Im Y.H., Parks W.T., Chen L., Zhou Y.X., Weinstein M., Kim S.J., Deng C.X. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene. 19:2000;1868-1874.
20. Takaku K., Miyoshi H., Matsunaga A., Oshima M., Sasaki N., Taketo M.M. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res. 59:1999;6113-6117.
21. Kang S.H., Bang Y.J., Jong H.S., Seo J.Y., Kim N.K., Kim S.J. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells. Br. J. Cancer. 80:1999;1144-1149.
22. Beck C., Schreiber H., Rowley D. Role of TGF-beta in immune-evasion of cancer. Microsc. Res. Tech. 52:2001;387-395.
23. Howe J.R., Roth S., Ringold J.C., Summers R.W., Jarvinen H.J., Sistonen P., Tomlinson I.P., Houlston R.S., Bevan S., Mitros F.A., Stone E.M., Aaltonen L.A. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 280:1998;1086-1088.
24. Wotton D., Lo R.S., Lee S., Massague J. A Smad transcriptional corepressor. Cell. 97:1999;29-39.
25. Kim D.H., Kim S.J. Transforming growth factor-beta receptors: role in physiology and disease. J. Biomed. Sci. 3:1996;143-158.
26. Shitara Y., Yokozaki H., Yasui W., Takenoshita S., Nagamachi Y., Tahara E. Mutation of the transforming growth factor-beta type II receptor gene is a rare event in human sporadic gastric carcinomas. Int. J. Oncol. 12:1998;1061-1065.
27. Park B.J., Park J.I., Byun D.S., Park J.H., Chi S.G. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Res. 60:2000;3031-3038.
28. Giehl K., Seidel B., Gierschik P., Adler G., Menke A. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene. 19:2000;4531-4541.
29. Fink S.P., Swinler S.E., Lutterbaugh J.D., Massague J., Thiagalingam S., Kinzler K.W., Vogelstein B., Willson J.K., Markowitz S. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line. Cancer Res. 61:2001;256-260.
30. Iglesias M., Frontelo P., Gamallo C., Quintanilla M. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Oncogene. 19:2000;4134-4145.
31. Yakymovych I., Ten Dijke P., Heldin C.H., Souchelnytskyi S. Regulation of Smad signaling by protein kinase C. FASEB J. 15:2001;553-555.
32. Kretzschmar M. Transforming growth factor-beta and breast cancer: transforming growth factor-beta/SMAD signaling defects and cancer. Breast Cancer Res. 2:2000;107-115.